Cargando…
A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366830/ https://www.ncbi.nlm.nih.gov/pubmed/30774767 http://dx.doi.org/10.18632/oncotarget.26591 |